Gyre Therapeutics Inc (GYRE)

SG&A Expense Growth

16.79%

Fiscal year · Period ending:

GYRE logo

GYRE SG&A Expense Growth

Latest reported16.79%
GYRE FY SG&A Growth (YoY) (0.00% → 16.79%)
High-resolution chart · PNG

GYRE sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
16.793%
-2.9029%
5.8834%
280.4888%
16.3164%
21.9108%
7.4308%
23.6265%
7.8925%
-3.4605%
136.5969%
-66.2224%
-9.0048%
8.4326%
51.1053%
-1.4081%
25.6655%
-18.8902%
40.6674%
-10.8369%
23.7476%
43.4021%
-12.9383%
79.6264%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.